ENTERA BIO LTD. Number Of Share Options Exercisable In Share-based Payment Arrangement
ENTERA BIO LTD. (ENTX) had Number Of Share Options Exercisable In Share-based Payment Arrangement of 1.79 million shares as of 2020-12-31, per its 20-F filed 2021-03-18.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement · last filed 2021-03-18
- 2020-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 1.79M shares.
- 2019-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 1.53M shares.
- 2018-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 1.84M shares.
- 2017-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 1.43M shares.
| Period end | Number Of Share Options Exercisable In Share-based Payment Arrangement |
|---|---|
| 2020-12-31 | 1.79M shares 20-F · filed 2021-03-18 |
| 2019-12-31 | 1.53M shares 20-F · filed 2021-03-18 |
| 2018-12-31 | 1.84M shares 20-F · filed 2021-03-18 |
| 2017-12-31 | 1.43M shares 20-F · filed 2020-03-26 |
| 2016-12-31 | 835.38K shares 20-F · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |